Insiders · Profile

Gold Kelly

Chief Financial Officer at Camp4 Therapeutics. Filing since 11 Sep 2025. CIK 0002033333

Company
Date
Role
Action
Shares
Amount
Of holding
31 Aug 2026
Chief Financial Officer
Bought
10,000
$39.60K
opened
3 Aug 2026
Chief Financial Officer
Bought
6,551
$10.81K
9.7%
11 Sep 2025
Chief Financial Officer
Bought
6,060
$10.00K
9.8%
3 decisions on file.